Genticel SA (GTCL)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Genticel SA (GTCL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013240
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genticel SA (Genticel), formerly BT Pharma, is a biopharmaceutical company that develops therapeutic vaccines for women infected by the human papillomavirus. The company provides pipeline products including ProCervix, a bivalent HPV therapeutic vaccine candidate and multivalent candidate vaccines for patients infected with HPV. It offers technologies such as CyaA vector platform and Vaxiclase for developing products. Genticel also provides clinical trials services. The company’s ProCervix is used for women infected with HPV 16 or HPV 18, before high grade lesions or cervical cancer occur. It operates in Paris and Labege. Genticel is headquartered in Labege, France.

Genticel SA (GTCL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genticel SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genticel SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genticel SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genticel SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Genticel SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Genticel SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Genticel Raises US$23.7 Million In Series C Financing 10
Partnerships 12
Genticel Enters into Agreement with Roche Molecular Systems 12
Merger 13
Genticel Merges with GenKyoTex 13
Licensing Agreements 15
Genticel Enters into Licensing Agreement with Serum Institute of India 15
Equity Offering 16
Genticel Completes IPO For USD47.7 Million 16
Genticel SA – Key Competitors 17
Genticel SA – Key Employees 18
Genticel SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Jan 30, 2017: Genticel Business Update-Fourth Quarter 2016 20
Oct 27, 2016: Genticel: Business Update – Third Quarter 2016 22
Sep 22, 2016: Genticel Presents First Half 2016 Financial Results And Updates Its Operational Outlook 23
Jul 28, 2016: Genticel: Business Update – Second Quarter 2016 26
Mar 14, 2016: Genticel Announces 2015 Annual Results and Strategic Update for 2016 27
Jan 25, 2016: Business Update – Fourth Quarter 2015 30
Corporate Communications 32
Jan 05, 2016: Genticel Appoints Remi Palmantier, PhD, as Chief Scientific Officer to Accelerate Its Development 32
Other Significant Developments 33
Apr 28, 2016: Genticel Provides Business Update – First Quarter 2016 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Genticel SA, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Genticel SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Genticel SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Genticel SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Genticel SA, Deals By Therapy Area, 2011 to YTD 2017 8
Genticel SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Genticel Raises US$23.7 Million In Series C Financing 10
Genticel Enters into Agreement with Roche Molecular Systems 12
Genticel Merges with GenKyoTex 13
Genticel Enters into Licensing Agreement with Serum Institute of India 15
Genticel Completes IPO For USD47.7 Million 16
Genticel SA, Key Competitors 17
Genticel SA, Key Employees 18
Genticel SA, Other Locations 19

★海外企業調査レポート[Genticel SA (GTCL)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cyan Limited:企業の戦略・SWOT・財務情報
    Cyan Limited - Strategy, SWOT and Corporate Finance Report Summary Cyan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sammons Enterprises Inc:企業の戦略・SWOT・財務情報
    Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Sammons Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Zogenix Inc (ZGNX):企業の財務・戦略的SWOT分析
    Zogenix Inc (ZGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Lechwerke AG (LEC):企業の財務・戦略的SWOT分析
    Summary Lechwerke AG (LechWerke), a subsidiary of Innogy SE is a utility service provider that offers electricity products natural gas products and energy services. The company provides services such as electrical safety, gas safety, energy monitoring, power plant contracting, street lighting, energ …
  • Jordan French Insurance Co. (P.L.C.):企業の戦略・SWOT・財務情報
    Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report Summary Jordan French Insurance Co. (P.L.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Senseonics Inc:企業の戦略的SWOT分析
    Senseonics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Genera Biosystems Ltd (GBI):企業の製品パイプライン分析2018
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • 3-D Matrix Ltd (7777):企業の財務・戦略的SWOT分析
    3-D Matrix Ltd (7777) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • The American Energy Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary The American Energy Group Ltd (American Energy Group), formerly Belize-American Corp, is an oil and natural gas company that develops, explores, acquire, and produces oil and natural gas producing assets. The company owns interest in two oil and gas leases in Southeast Texas American Energy …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • NeoPharm Co Ltd:企業の戦略・SWOT・財務情報
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Guardian Industries Corp:企業の戦略的SWOT分析
    Guardian Industries Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Mitsubishi Corporation:企業の戦略・SWOT・財務情報
    Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sirius XM Holdings Inc.:戦略・SWOT・企業財務分析
    Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lotus Pharmaceutical Co Ltd (1795):製薬・医療:M&Aディール及び事業提携情報
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • Universal Hospital Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Universal Hospital Services Inc (UHS) is a clinical equipment service company that offers medical equipment management and service solutions. The company offers equipment services and equipment rental services. Its equipment services include clinical engineering, on-site management, surgical …
  • Teijin Limited:企業のM&A・事業提携・投資動向
    Teijin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teijin Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • PolyOne Corp (POL):企業の財務・戦略的SWOT分析
    PolyOne Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Evolution Petroleum Corp (EPM):石油・ガス:M&Aディール及び事業提携情報
    Summary Evolution Petroleum Corp (EPC), a subsidiary of Esrey Resources Ltd, is an oil and gas company that acquires and explores crude oil and natural gas properties. The company explores for oil, liquefied gas, natural gas, and gas reserves in Delhi field CO2-EOR project. It offers GARP or gas ass …
  • Ferrellgas Partners LP (FGP):石油・ガス:M&Aディール及び事業提携情報
    Summary Ferrellgas Partners LP (Ferrellgas) is an oil and gas company that supplies propane and related equipment. The company provides transportation, wholesale marketing, and distribution of propane. It also carries out selling refined fuels and feedstocks. Ferrellgas provides propane crop drying, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆